AUG 22, 2013 1:00 PM PDT

Dominant regulation of gene expression by microRNAs

Speakers
  • Principle Investigator, Genome Laboratory, Tel Aviv University
    Biography
      Dr. Noam Shomron heads a research team which focuses on the analysis of genomic sequences and gene expression aimed at understanding human diseases. Dr Shomron trained at Massachusetts Institute of Technology (MIT, Cambridge, MA, USA) where he combined high-throughput methods with computational analysis. Dr Shomron joined Tel Aviv University's Medical School in October 2008. Dr Shomron's is highly skilled in deep (next generation) sequencing technologies, in addition to parsing and processing the sequencing output. His strength in the genomic world stems from his extensive experience and knowledge using state-of-the-art methods both experimentally and computationally. Dr Shomron's overall interest and goals lie within seeking a better understanding of the mechanisms leading to disease development. His team seeks innovative solutions to generate a significant impact through translating ideas into clinical reality. Dr Shomron is also the Director of Rare Genomics Institute's Israel branch; co-founder and Scientific Director of the Functional Genomics Laboratory at Tel Aviv University; Editor-in-Chief of ‘Genetics Research' (published by Cambridge University Press); Editor of ‘Deep Sequencing Data Analysis' (a ‘Methods in Molecular Biology' book series published by Springer/Humana Press), Academic Director of BioAbroad.

    Abstract:
    MicroRNAs are short non-coding cellular regulators of gene expression. Each microRNA controls the expression of a large set of genes, and microRNAs collectively, may regulate more than half of human genes. In the laboratory, our team focuses on understanding the function of microRNAs in health and during disease. We map their expression in developing cancer cells and in various brain disorders. We predict direct gene targets of these microRNAs sets and then pinpoint the cellular pathways affected. I will present our recent findings in the field and discuss its potential implications for prognosis and diagnosis. Overall our team pursues research that aims to deepen our understanding on the development of diseases in order to generate a significant impact through translating ideas into clinical reality.

    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    NOV 18, 2019 7:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 7:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    FEB 26, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    Loading Comments...
    Show Resources